AMGEN INC (AMGN)
Clinical trial NCT03600883 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-30 → 2026-05-29 3. primary completion date: 2026-05-30 → 2026-05-29
Clinical trial NCT03600883 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-30 → 2026-05-29 3. primary completion date: 2026-05-30 → 2026-05-29
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical